Evolving Nuclear Medicine; Changes in Daily Practice and Future Outcomes

Abstract

The Nuclear Medicine practice is based on diagnostic and therapeutic directions which are always prone to the improvements due to close interaction with technology. The revolutions in Nuclear Medicine brought recent advances day by day to the daily practice and becomes the way it is. Today Nuclear Medicine preserves the role in the treatment of Differentiated Thyroid carcinoma by I-131 as well as new treatment options by new radiopharmaceuticals like Lu-177 and Ra-223 exists. Imaging of Tc-99m labelled compounds preserves their role in imaging as well as the growing role of F-18 FDG PET/CT is supported and re-directed by recent advances on FAPI and FDG PET/MR in the field of Oncology. While sentinel lymph node imaging during oncologic surgery becomes the standard procedure recent advances provides intraoperative gamma imaging by real time imaging procedures.